Skip to main content

Esophageal Cancer clinical trials at UCSF
3 in progress, 1 open to new patients

  • APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers

    open to eligible people ages 18 years and up

    This study evaluates APX005M, in combination with chemoradiation, in patients with resectable cancers of the esophagus and gastroesophageal (GE) junction, including both squamous cell and adenocarcinomas.

    San Francisco, California

  • Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer

    Sorry, in progress, not accepting new patients

    RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining chemotherapy with radiation therapy after surgery may kill any remaining tumor cells following surgery. It is not yet known which chemotherapy and radiation therapy regimen is more effective in treating stomach or esophageal cancer.

    PURPOSE: Randomized phase III trial to compare two different chemotherapy and radiation therapy regimens in treating patients who have undergone surgery for stomach or esophageal cancer.

    San Francisco, California and other locations

  • PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

    Sorry, in progress, not accepting new patients

    RATIONALE: PET scans done during chemotherapy may help doctors assess a patient's response to treatment and help plan the best treatment.

    PURPOSE: This randomized phase II trial is studying PET scan imaging in assessing response in patients with esophageal cancer receiving combination chemotherapy.

    San Francisco, California and other locations